Medical Condition: Alpha-1 Antitrypsin Deficiency
Facility/Clinic: PMG Research of Wilmington
A research study is evaluating an investigational medication that may slow the progression of alpha-1 antitrypsin deficiency in patients with emphysema.
This research study may be an option if you:
· Have a clinical diagnosis of alpha-1 antitrypsin deficiency
· Have evidence of emphysema
· Have been a non-smoker for at least 12 months
· Have no history of moderate to severe liver fibrosis
Other criteria apply. Please make sure to discuss with a member of our research staff to ensure this research study is a good fit for you.
Qualified participants will receive all study-related care and study medication at no cost.
Patient Commitment Duration: Approximately 5 months
Number of visits in study: Approximately 9 clinic visits and 2 phone calls
Patient Compensation: Financial compensation may be provided for time and travel expenses
Apply for this study below:
The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial.
Please call 910-799-5500 between the hours of 8am-5pm for general research questions.